Merck in Austin?

Pharma firm considers “Innovation” location, Austin city incentives

Friday afternoon, March 31, the city of Austin announced a proposal to provide economic incentives to New Jersey-based pharmaceutical firm Merck & Co., in return for the creation of 600 jobs and a total proposed investment of $28.7 million in a company IT hub, eventually planned for the “Innovation Zone” near the Dell Medical School complex.

City Council will be briefed on the proposal at its April 6 meeting next Thursday (public comment invited), with a full public hearing and a possible vote the following week. According to a statement released by the Economic Development Department, “The City’s proposal includes a performance-based investment of $856,000 over a 10-year period.” Both the Central Health Care District and the Dell Medical School would be expected to collaborate in partnerships with Merck.

Documents posted with the Council briefing materials include a summary of the major aspects of the proposed deal:

• Merck (Merck Sharp & Dohme Corporation) anticipates an investment of $20,532,000 million in construction, as well as an estimated $2 million in annual expenditures for local services and an estimated $500,000 in annual local purchases.

• The Austin project would establish Merck’s fourth IT Hub, to be focused on metadata collection and designing solution-based platforms for personalized, proactive and preventative healthcare.

• Although the company is reportedly considering several other locations, should it choose Austin, it anticipates finding a short-term, lease space, while a future long-term space is constructed within the Innovation Zone. (A potential location would be the mixed-used development planned for the current University Medical Center Brackenridge site. (UMC Brackenridge is to be replaced by the nearly complete Dell Seton Medical Center.)

• The Merck agreement with the city would have a 10-year term, eventually resulting in 600 permanent jobs with an average wage of $84,586, and a median wage of $79,500 by 2026.

The city’s anticipated $856,000 contribution is relatively small (about $200 per job), although it will reportedly function as the local sponsor of and complement to expected state incentives from the Texas Enterprise Fund (not yet announced). The city incentives will be performance-based (paid only in return for annual employment and investment benchmarks). According to a city financial summary, over 10 years the city expects gross benefits of $10,296,672, and gross costs of $8,348,568 – for a calculated net benefit of $1,948,104.

As attractive to city officials as any direct financial return is the opportunity to create a major medical “innovation” partnership with the Dell Medical School within the city’s north Downtown Innovation Zone. In a statement, Medical School Dean Clay Johnston said in part, “While a number of details need to be worked out, a collaborative relationship with this company could create unique opportunities to fulfill our mission in different and far-reaching ways.

“We have discussed projects and initiatives to improve health, reduce inequities, improve patient outcomes and lower community health costs – potentially ranging from an effort to eradicate human papillomavirus (HPV) and cervical cancer in Austin, to pilot projects around better uses of health data, to community-based programs that increase the pipeline from schools into the health professions. These kinds of initiatives would be difficult to achieve without a relationship with this specific kind of collaborator. …

“We look forward to working with the city and the company to ensure that this community can seize every available opportunity to make Austin a model healthy city that’s an example to the world.”

You can review more information about the proposal, and participate in an online survey, on the city's Economic Development Department website. For more on the Merck proposal and this week’s City Council meeting, follow the Daily News and the April 7 print edition.

A note to readers: Bold and uncensored, The Austin Chronicle has been Austin’s independent news source for over 36 years, expressing the community’s political and environmental concerns and supporting its active cultural scene. Now more than ever, we need your support to continue supplying Austin with independent, free press. If real news is important to you, please consider making a donation of $5, $10 or whatever you can afford, to help keep our journalism on stands.

Support the Chronicle  

READ MORE
More City Council 2017
Some Say the World Will End … in Ice
Council Wrap Dec. 7, 2017
City Council dodges the ice storm, and much of its agenda

Michael King, Dec. 11, 2017

A Two-Horse Race
City Manager Search
Council selects finalists for city manager – public meeting Tuesday

Michael King, Dec. 8, 2017

More Merck & Co.
Merck CEO Dumps Trump
Merck CEO Dumps Trump
CEO Frazier leaves manufacturing council over POTUS failure on racism

Michael King, Aug. 14, 2017

More by Michael King
Point Austin: This Most Important Election
Point Austin: This Most Important Election
How and why the Chronicle takes endorsements seriously

Oct. 19, 2018

Council Poised to Bless Camelback
Council Poised to Bless Camelback
Neighbors bet on one developer to save them from another

Oct. 19, 2018

KEYWORDS FOR THIS POST

City Council 2017, Merck & Co., economic incentives, Dell Medical School, Innovation Zone

MORE IN THE ARCHIVES
NEWSLETTERS
One click gets you all the newsletters listed below

Breaking news, arts coverage, and daily events

Can't keep up with happenings around town? We can help.

Austin's queerest news and events

Updates for SXSW 2019

All questions answered (satisfaction not guaranteed)

Information is power. Support the free press, so we can support Austin.   Support the Chronicle